Skip to content

CapEx at other companies

Boston Scientific logo
Boston ScientificBSX
$177M-5.3%
Medtronic logo
MedtronicMDT
$488M+6.3%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$6.61M+6.4%
Nuvation Bio logo
Nuvation BioNUVB
$48K-33.3%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$390K-76.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$2K-104%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.64B-36.7%
Enterprise value$1.59B-36.3%
P/S2.4×-1.7×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's capex?
NovoCure (NVCR) reported capex of $5.15M in Q1 2026.
How has NovoCure's capex changed year-over-year?
NovoCure's capex decreased by 51.4% year-over-year, from $10.61M to $5.15M.
What is the long-term trend for NovoCure's capex?
Over 4 years (2021 to 2025), NovoCure's capex has grown at a 2.5% compound annual growth rate (CAGR), from $24.17M to $26.65M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.